Immunochina Company
%20.jpg)
Immunochina Pharmaceuticals produces cell injections, cell therapy drugs, and other products and provides medical technology development.
Total Funding:
9-25
Headquarters:
China
Funding Status:
Late Stage Venture
Employee Number:
43840
Last Funding Type:
Series C
Technology:
Regenerative Medicine
Investor Type:
For Profit
Last Funding Date:
43487
Investors Number:
8
Founded Date:
4-1
Industry:
Biotechnology, Clinical Trials, Medical, Medical Device, Pharmaceutical